Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
0.00%
)
US TECH 100
23,626.80
(
-0.71%
)
Dow Jones
46,225.15
(
0.00%
)
Brent Oil
109.17
(
2.43%
)
Bitcoin
69,688.72
(
-2.18%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

gfp927z

Send PM Follow Ignore
Followers 97
Posts 38497
Boards Moderated 89
Alias Born 03/22/2005

gfp927z

Re: DewDiligence post# 71113

Thursday, 01/08/2009 2:03:09 PM

Thursday, January 08, 2009 2:03:09 PM

Post# of 257257
Thanks Dew. Just wondering how you now see Anadys as an investment, in light of today's clinical data? Their 2008 year end cash level is in the $25-27 mil range (as per today's conf call), and the CEO indicated they've been in partnering discussions with multiple parties for the Hep C program since Fall '08. Market cap now just over $100 mil. Any thoughts on additional nearterm upside vrs a pullback? Thanks for any insights.














Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now